The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
Cheshire West based start-up CaffiClear has been working with Digital Cheshire
Read More
Cheshire West based start-up CaffiClear has been working with Digital Cheshire
K3 Advisory Group acquires self-invested pensions specialist
Read More
K3 Advisory Group acquires self-invested pensions specialist
arch.law snaps up solicitors firm which works with clients across the North
Read More
arch.law snaps up solicitors firm which works with clients across the North